UpHealth

UpHealth, Inc. operates as a digital health company. It integrates care delivery across the globe to support healthier individuals and communities. It operates through the following segments: the Integrated Care Management, the Global Telehealth, the Digital Pharmacy, the Behavioral Health and the Corporate. The Integrated Care Management segment provides customers with an advanced and extensible technology platform, marketed under the umbrella “SyntraNetTM” to manage health, quality of care, and costs, especially for individuals with complex medical, behavioral health, and social needs. The Global Telehealth segment provides customers with primary care, specialty consultations, and translation services, through telemedicine, digital dispensaries, and technology-based hospital centers. The Digital Pharmacy segment provides custom compounded medications for the unique needs of every patient and prescriber. The Behavioral Health segment provides inpatient and outpatient substance abuse and mental health treatment services for individuals with drug and alcohol addiction and other behavioral health issues. It also offers a complete continuum of care from detoxification services, residential care, partial hospitalization programs, and intensive outpatient and outpatient programs. The Corporate segment performs executive, administrative, finance, human resources, legal, and information technology services for the company. The company was founded by Chirinjeev Kathuria and Mariya Pylypiv and is headquartered in Delray Beach, FL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

UpHealth, Inc. operates as a digital health company. It integrates care delivery across the globe to support healthier individuals and communities. It operates through the following segments: Integrated Care Management, Global Telehealth, Digital Pharmacy, Behavioral Health, and Corporate. The Integrated Care Management segment provides customers with an advanced and extensible technology platform, marketed under the umbrella “SyntraNetTM” to manage health, quality of care, and costs, especially for individuals with complex medical, behavioral health, and social needs. The Global Telehealth segment provides customers with primary care, specialty consultations, and translation services, through telemedicine, digital dispensaries, and technology-based hospital centers. The Digital Pharmacy segment provides custom compounded medications for the unique needs of every patient and prescriber. The Behavioral Health segment provides inpatient and outpatient substance abuse and mental health treatment services for individuals with drug and alcohol addiction and other behavioral health issues. It also offers a complete continuum of care from detoxification services, residential care, partial hospitalization programs, and intensive outpatient and outpatient programs. The Corporate segment performs executive, administrative, finance, human resources, legal, and information technology services for the company. The company was founded by Chirinjeev Kathuria and Mariya Pylypiv on November 5, 2019 and is headquartered in Delray Beach, FL.

Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla. , July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replacing Martin Beck, who resigned as Chief Executive Officer effective July 10, 2024.

UpHealth Announces CEO Transition and Organizational Changes

UpHealth Inc

DELRAY BEACH, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth”) (OTC: UPHL), a leading provider of a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services, today provided an update on the efforts of UpHealth Holdings, Inc. (“Holdings”), a wholly-owned direct subsidiary of UpHealth, to enforce the International Court of Arbitration of the International Chamber of Commerce (the “ICA”)'s Final Award to Holdings and against Glocal Healthcare Systems (“Glocal”) and several of Glocal's officers and shareholders (together with Glocal, the “Respondents”).

UpHealth Holdings Takes Steps to Enforce the International Court of Arbitration's Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

~ Glocal Ruling from Arbitral Tribunal in Favor of Company for up to $110.2 Million in Damages ~ ~ Sale of Cloudbreak Health Business Closed on March 15, 2024 ~ ~ Gross Cash Proceeds of $180 Million from the Cloudbreak Sale Will Be Used to Pay Down Debt, Including All of the Company's $115 Million 2026 Notes and a Substantial Portion of its $57.2 Million 2025 Notes ~ ~ Continues Simplification Strategy Focused on Profitable TTC Behavioral Healthcare Business ~ DELRAY BEACH, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“we,” “UpHealth,” or the “Company”) (OTC: UPHL) today provided a corporate update and announced financial results for the fourth quarter and full year ended December 31, 2023.

UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

DELRAY BEACH, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth”) (OTC: UPHL), a global digital health company delivering a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services, today provided an update on the arbitration brought by UpHealth Holdings, Inc., a wholly-owned direct subsidiary of UpHealth (“Holdings”), against Glocal Healthcare Systems (“Glocal”) and several of Glocal's officers and shareholders (together with Glocal, the “Respondents”). On March 18, 2024, the International Court of Arbitration of the International Chamber of Commerce (the “ICA”) transmitted the Final Award to the parties. In the Final Award, the arbitral tribunal (“Tribunal”) found the Respondents liable for breach of contract and directed them to pay Holdings up to $110.2 million in damages, as well as most of the legal costs and other expenses that Holdings incurred in the arbitration. The $110.2 million damages are apportioned based on the shareholders percentage of each of the Indian directors and shareholders of Glocal: 34.38% to be paid by Dr. Syed Sabahat Azim, 34.38% by Richa Sana Azim, 4.69% by Mr. Gautam Chowdhury, 22.54% by Mr. Meleveetil Damodaran, and 4.02% by Kimberlite Social India Private Limited.

The International Court of Arbitration awarded UpHealth Holdings more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“we,” “our,” “UpHealth,” or the “Company”) (NYSE: UPHL) today announced that it completed its previously announced sale of Cloudbreak Health, LLC (“Cloudbreak”), best known for its Martti™ translation offering, to a newly formed entity controlled by GTCR LLC for $180 million in gross cash proceeds on March 15, 2024.

UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of UpHealth, Inc. (the “Company”) — ticker symbol UPH — from the NYSE. Trading in the Company's common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company's common stock pursuant to Section 802.01B of the NYSE's Listed Company Manual because the Company had f.

NYSE to Commence Delisting Proceedings Against UpHealth, Inc. (UPH)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the redeemable warrants of UpHealth, Inc. (the “Company”), exercisable for one share of common stock at an exercise price of $115.00 per share (the “Warrants”) — ticker symbol UPH.WS — from the NYSE. Trading in the Company's Warrants will be suspended immediately. Trading in the Company's common stock — ticker symbol U.

NYSE to Commence Delisting Proceedings with Respect to the Warrants of UpHealth, Inc. (UPH.WS)

DELRAY BEACH, Fla., Nov. 21, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth,” or the “Company”) (NYSE: UPH), today announced that the Company has resumed trading on the New York Stock Exchange (“NYSE”) under the symbol “UPH.”  Trading of UPH resumed, today on November 21, 2023, at market open following the disclosures provided in the November 20, 2023 filings, accessible via the Company's Investor Relations website and the Securities and Exchange Commission at www.sec.gov .

UPHEALTH RESUMES TRADING ON THE NEW YORK STOCK EXCHANGE

~ Posts Strong Year Over Year Revenue Growth in Telehealth and Behavioral Health Businesses, Gross Margin Expanded to 54% and $5.4 million in Adjusted EBITDA ~  ~ Reviews in Detail the Voluntary Chapter 11 Protection Filings of One Division of UpHealth, Inc., UpHealth Holdings, Inc., and Certain of its Subsidiaries ~  ~ Entered into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million ~  ~ Simplifies Strategy and Focuses on Profitable TTC, Behavioral Healthcare Business ~

UpHealth Provides Corporate Update And Issues Financial Results For The Third Quarter Of 2023

Leading video-focused language interpretation service provider to become independent company CHICAGO , Nov. 16, 2023 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has signed a definitive agreement to acquire Cloudbreak Health, LLC ("Cloudbreak" or "the Company"), a leading provider of tech-enabled, healthcare-focused language interpretation services, in a corporate carve-out transaction from UpHealth, Inc. ("UpHealth", NYSE: UPH). Under the terms of the agreement, the purchase price is $180 million, and the transaction is expected to close in the first quarter of 2024 following the receipt of customary regulatory and stockholder approvals and closing conditions.

GTCR to Acquire Cloudbreak Health

Proceeds Will be Utilized to Pay Down All Unsecured Debt and Approximately 45% of Secured Debt UpHealth Will Focus on TTC Healthcare, A Growing, Cash Flow Positive Behavioral Health Business DELRAY BEACH, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth,” the “Company”) (NYSE: UPH), today announced that it has entered into a definitive agreement to sell its wholly-owned subsidiary Cloudbreak Health, LLC (“Cloudbreak”), best known for its Martti translation offering, to GTCR for $180 million in cash.

UpHealth Enters into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million

Parent UpHealth, Inc. and its Direct and Indirect Subsidiaries, Cloudbreak Health, LLC and TTC Healthcare, Inc., Have NOT Filed for Chapter 11 Protection and are Operating in the Normal Course of Business

Thrasys, Inc., a Subsidiary of Debtor UpHealth Holdings, Inc., Files Voluntary Reorganization Under Chapter 11 of the U.S. Bankruptcy Code

Shares of UpHealth Inc. UPH, -18.35% plummeted 50% toward a record low in premarket trading Tuesday, after the digital health company declared for bankruptcy. The company, which went public public on June 10, 2021 after the completion of its merger with special purpose acquisition company (SPAC) GigCapital2 Inc., said it expects to keep operating “in the normal course.

UpHealth stock loses half its value after unfavorable court ruling leads to bankruptcy filing

Believes Court Erred by Ignoring Settled New York Law and Decades of Precedent Company is Exploring All Options in Response to Ruling DELRAY BEACH, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth,” the “Company,” “we” or “us”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today provided an update on the legal action Needham & Company LLC v.

UpHealth Comments on Needham Action Ruling

GEM HEALTH is a nationwide virtual clinic providing timely, convenient, and insurance-accessible specialty care services GEM SLEEP provides a focused and simplified end-to-end solution, from diagnosis through treatment and support, for those who may have obstructive sleep apnea GEM secured a Seed round of financing led by HealthTrend Capital, with participation from Base10 Partners and Mairs & Power Venture Capital MINNEAPOLIS , Sept. 11, 2023 /PRNewswire/ -- Gem Specialty Health, Inc. ( GEM HEALTH ), a nationwide digital specialty care clinic, announced today it has successfully raised a Seed financing round led by HealthTrend Capital , with participation from existing investor Base10 Partners  and new investor Mairs & Power Venture Capital.

GEM HEALTH Raises Additional Financing to Expand GEM SLEEP Virtual Care to Millions of People Suffering from Sleep Conditions

~ 2023 Ranking Marks Third Consecutive Inclusion for Delray Beach Facility ~ ~ 2023 Ranking Marks Third Consecutive Inclusion for Delray Beach Facility ~

UpHealth's Transformations Treatment Center Recognized as One of America's Best Addiction Treatment Centers for 2023

UpHealth, Inc. (NYSE:UPH ) Q2 2023 Results Conference Call August 10, 2023 5:00 PM ET Company Participants Shannon Devine - IR Sam Meckey - CEO Martin Beck - CFO Conference Call Participants Bill Sutherland - Benchmark Company Ben Haynor - Alliance Global Partners Mike Latimore - Northland Capital Operator Greetings, and welcome to UpHealth Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

UpHealth, Inc. (UPH) Q2 2023 Earnings Call Transcript

UpHealth, Inc. (UPH) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.90 per share a year ago.

UpHealth, Inc. (UPH) Reports Q2 Loss, Tops Revenue Estimates

Second Quarter Revenues Were $37.8 million and Gross Margin Expanded to 53%

UpHealth Announces Second Quarter 2023 Financial Results

DELRAY BEACH, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its second quarter ended June 30, 2023, after market close on Thursday, August 10, 2023.

UpHealth Announces Timing of Second Quarter 2023 Earnings Release and Conference Call

DELRAY BEACH, Fla., June 20, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc., a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced management will be participating at the NYSE Health & Technology Virtual Investor Access Day on Thursday, June 22nd, 2023.

UpHealth Announces Participation at NYSE Health & Technology Virtual Investor Access Day on June 22, 2023

DELRAY BEACH, Fla., June 01, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc., a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced management will be participating at the LD Micro Invitational XIII Conference being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA on June 6-8, 2023.

UpHealth to Participate at LD Micro Invitational XIII Conference on June 6, 2023

UpHealth, Inc. (NYSE:UPH ) Q1 2023 Earnings Conference Call May 11, 2023 5:00 PM ET Company Participants Shannon Devine - Investor Relations Sam Meckey - Chief Executive Officer Martin Beck - Chief Financial Officer Conference Call Participants Mike Latimore - Northland Capital Markets Bill Sutherland - The Benchmark Company Operator Greetings, and welcome to UpHealth's First Quarter 2023 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode.

UpHealth, Inc. (UPH) Q1 2023 Earnings Call Transcript

First Quarter Revenues Increased 17% to $42.1 million First Quarter Gross Margin Expanded to 54% First Quarter Net Loss Attributable to UpHealth, Inc. Decreased 54% to $8.1 million First Quarter Adjusted EBITDA Improved by $7.9 million to $6.6 million Announced Strategic Sale of Innovations Group, Inc. for $56.0 million

UpHealth Announces First Quarter 2023 Financial Results

~ Closing Represents Substantial Completed Milestone and Execution of Strategic Vision ~ ~ Transaction Delivers $56.0 Million to Company's Balance Sheet ~ DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced it has completed the divestiture of Innovations Group, Inc., (“IGI”), including its compounding pharmacy subsidiary, MedQuest Pharmacy, Inc., completing the asset sale to Belmar Pharma Solutions for $56.0 million in gross proceeds.

News for UpHealth Stock (UPH)